TORONTO, July 19, 2018 /PRNewswire/ --
Eyecarrot Innovations Corp ("Eyecarrot" or the "Company") (TSX-V: EYC) (OTCQB: EYCCF) is pleased to announce it has secured a distribution deal with the leading Australasian Behavioural Optometric group ACBO ("The Australasian College of Behavioural Optometrists"). Eyecarrot recently attended the 8th International Congress of Behavioural Optometry in Sydney where the Binovi Platform was popular with many attendees. The company will now work with ACBO to follow through on its first shipment of 40 Binovi Touch units into the Australasian marketplace.
"ACBO has been the leading group of Behavioural Optometrists in Australasia for many decades now and is an incredibly effective and efficient organization. Our Binovi Platform was very well received during our recent trip to Sydney and we have prioritized shipment of units to that region during the third quarter. We are looking forward to be working with ACBO and the ability to extend our platform globally and expect to penetrate the Australasian market with hundreds of units," commented CEO, Adam Cegielski.
About the Australasian College of Behavioural Optometrists
The Australasian College of Behavioural Optometrists (ACBO) was founded in 1987, and provides Australian, New Zealand and Asian Optometrists with education and training in behavioural optometry. Its members have special interest in children's vision, patients with learning difficulties, traumatic brain injury, binocular vision dysfunction, as well as those wishing to enhance their visual skills. ACBO is the professional association for independent optometrists who wish to differentiate themselves by focusing on functional vision care, neurodevelopmental optometry and vision therapy.
Eyecarrot's BinoviTM platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient's experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.
On behalf of the Board of Directors
President | CEO
Forward looking information
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at http://www.sedar.com. The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Eyecarrot Innovations Corp